ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 62 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 4.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $2,649,000 | – | 272 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prentice Capital Management, LP | 390,381 | $1,292,000 | 0.49% |
ETF MANAGERS GROUP, LLC | 891,025 | $2,949,000 | 0.09% |
AdvisorShares Investments LLC | 353,009 | $1,168,000 | 0.06% |
ALGERT GLOBAL LLC | 51,028 | $169,000 | 0.05% |
Bernardo Wealth Planning LLC | 27,219 | $90,000 | 0.04% |
IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 31,552 | $104,000 | 0.03% |
ZEKE CAPITAL ADVISORS, LLC | 49,700 | $165,000 | 0.02% |
Walleye Capital LLC | 51,554 | $171,000 | 0.02% |
Dynamic Technology Lab Private Ltd | 19,021 | $63,000 | 0.01% |
J.W. COLE ADVISORS, INC. | 37,064 | $123,000 | 0.01% |